共 28 条
[1]
The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)[J] Dennis M. Black;Ian R. Reid;Jane A. Cauley;Felicia Cosman;Ping Chung Leung;Peter Lakatos;Kurt Lippuner;Steven R. Cummings;Trisha F. Hue;Amitava Mukhopadhyay;Monique Tan;R. Paul Aftring;Richard Eastell J Bone Miner Res 2015,
[2]
The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta‐Analysis of Randomized Controlled Trials[J] Joshua R Lewis;Simone Radavelli‐Bagatini;Lars Rejnmark;Jian Sheng Chen;Judy M Simpson;Joan M Lappe;Leif Mosekilde;Ross L Prentice;Richard L Prince J Bone Miner Res 2015,
[3]
Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?[J] I. R. Reid;M. J. Bolland Osteoporosis International 2014,
[4]
Vitamin D supplements and bone mineral density – Authors' reply[J] Ian R Reid;Mark J Bolland;Andrew Grey The Lancet 2014,
[5]
Risk of Atypical Femoral Fracture during and after Bisphosphonate Use[J] Jörg Schilcher;Veronika Koeppen;Per Aspenberg The New England Journal of Medicine 2014,
[6]
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research[J] Elizabeth Shane;David Burr;Bo Abrahamsen;Robert A Adler;Thomas D Brown;Angela M Cheung;Felicia Cosman;Jeffrey R Curtis;Richard Dell;David W Dempster;Peter R Ebeling;Thomas A Einhorn;Harry K Genant;Piet Geusens;Klaus Klaushofer;Joseph M Lane;Fergus McKiernan;Ross McKinney;Alvin Ng;Jeri Nieves;Regis O'Keefe;Socrates Papapoulos;Tet Sen Howe;Marjolein CH v
[7]
Calcium risk–benefit updated—New WHI analyses[J] Ian R. Reid;Mark J. Bolland Maturitas 2014,
[8]
Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis[J] Prashanth Peddi;Maria A. Lopez-Olivo;Gregory F. Pratt;Maria E. Suarez-Almazor Cancer Treatment Reviews 2013,
[9]
Five years of anti-resorptive activity after a single dose of zoledronate — Results from a randomized double-blind placebo-controlled trial[J] Andrew Grey;Mark J. Bolland;Anne Horne;Diana Wattie;Meaghan House;Greg Gamble;Ian R. Reid Bone 2012,
[10]
Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self‐reporting in randomized controlled trials of calcium supplementation[J] Joshua RLewis;KunZhu;Richard LPrince J Bone Miner Res 2012,